AILERON THERAPEUTICS INC
SEC Filing List
ALRN CIK: 0001420565
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| DEF 14A | Definitive proxy statements | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/08/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/08/2026 | |
| ARS | Annual report to security holders | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/08/2026 | |
| PRE 14A | Preliminary proxy statement not related ... | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/28/2026 | |
| 4 | Statement of changes in beneficial owner... | Von Rickenbach Josef H | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/28/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |
| 4 | Statement of changes in beneficial owner... | Windsor James Brian | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/13/2026 | |
| SCHEDULE 13G | Toppan Merrill/FA | 05/08/2026 | |||
| SCHEDULE 13G/A | 05/08/2026 | ||||
| SCHEDULE 13G | Optima Partners Holdings LLC /fa | 05/07/2026 | |||
| No record found. | |||||
| Load More | |||||
